Results: Mindful breathing significantly reduced the dyspnea score among all patients in 5 min (OR = 12.886, 95% CI = 3.588, 46.282 , P < 0.001) and 20 minutes (OR = 5.378, 95% CI = 1.832, 15.790, P = 0.002), oxygen saturation in 5 min (OR = 4.050, 95% CI = 1.137, 14.432, P = 0.025) and respiratory rate in 20 min (OR = 3.069, 95% CI = 1.094, 8.613, P = 0.031).
P = 0.002), oxygen saturation in 5 min (OR = 4.050, 95% CI = 1.137, 14.432, P = 0.025) and respiratory rate in 20 min (OR = 3.069, 95% CI = 1.094, 8.613, P = 0.031).
Significant early dyspnea score reduction was observed in 5 min in mindful breathing group among patients with lung cancer. (P = 0.041) In a subgroup of patients with AEBA, mindful breathing conferred significant sustained dyspnea reduction in 5 min (P = 0.006); in 20 min (P = 0.003) and early oxygen saturation in 5 min (P = 0.039). In mindful breathing group among patients with AECOPD, a significant reduction in dyspnea score was observed in 5 minute (P = 0.034) while delayed respiratory rate improvement was demonstrated in 20 min (P = 0.035).
Conclusion:
Mindful breathing is a quick, easy and useful therapy and has a significant effect in dyspnea reduction among patients with lung diseases. Further studies with a larger sample size are recommended to discover more potential effects of mindful breathing in the subgroups of patients. Methods: A 32-year-old male, sought consult due to morning headaches and poor concentration which affects his work. Associated symptoms were snoring, witnessed apnoea, daytime sleepiness, and easy fatigability. Past medical history and family history were unremarkable. Sleep history revealed that patient has sudden awakening with intense anxiety, awakens with headache, with back pain and with heartburn, has difficulty waking up in the morning, and has trouble falling asleep. Epworth sleepiness scale is 19. BMI is 38 kg/m 2 and neck circumference is 18 inches. Chest findings were unremarkable. STOP BANG score was 6/8. Echocardiogram and arterial blood gas were normal.
Results: On diagnostic polysomnogram, respiratory disturbance index (RDI) was noted to be 101.3 events/h, with 77% obstructive apnoeas, 13% central apnoeas and 10% hypopneas. Central apnoea index was 13.1. Lowest oxygen saturation was 89%. During the CPAP titration study, central apnoea index increased to 57.2. The patient then underwent a repeat therapeutic polysomnogram since the ending pressures of the first titration study failed to normalize the RDI. On repeat titration study, at bi-level positive airway pressure (PAP) with pressures of IPAP 13, EPAP 5, back up rate of 12, there was resolution of the central apnoea events.
Conclusion: Management of treatment-emergent CSA is controversial, and treatment recommendations are derived from clinical experience, small observational studies, and a limited number of small randomized trials. For this case, titration with bi-level PAP was helpful in relieving the central apnoea events. shown similarities, the relationship suggested between the NAFLD and the impaired respiratory functions are shown for the first time by obtaining liver biopsy in this study.
Methods: 94 non-smoking patients 58♀, 36♂ who had NAFLD whose Activity Score (NAS) calculated for all patient after the biopsy. The control group 28♀&17♂out of 45 whose respiratory function test results (FEV1&FVC) received by spirometry. Between groups FEV1/FVC ratio had no significant difference, restrictive pattern value (10.8% vs17.5 P = 0.37).
In NAFLD group, insulin resistance seen to be significant as an independent predictor factor (P < 0.001).
Patients with NAFLD, a restrictive respiratory disease seen relatively as a frequent co-morbidity; insulin resistance on these two organs is regarded as a probable mechanism.
As their ethiopathology and results shown similarities, the relationship suggested between the NAFLD and the impaired respiratory functions are shown for the first time by obtaining liver biopsy in this study. Background and Aims: Obesity is known to have significant effects on pulmonary function. One of those features is forced oscillation technique (FOT) properties, so that higher respiratory system resistance (Rrs) and more negative reactance (Xrs) compared to subjects with normal body weight have been reported. In this study, effects of weight loss therapy on Rrs, Xrs, and other relevant parameters were examined. 42. AE .0 to 41. AE .3% (P < 0.01), respectively. SM and FFM composition rates were significantly increased from 26.9 AE 3.1 to 27.5 AE 3.2% (P < 0.01), and 57.6 AE 7.0 to 58.7 AE 7.3% (P < 0.01), respectively. Vital capacity (VC) and expiratory reserve volume (ERV) were increased from 3.6 AE 1.0 to 3.8 AE 1.0 L (P<0.01), and from 0.7 AE 0.5 to 0.9 AE 0.6 L (P < 0.01), respectively. R5 was significantly decreased from 4. AE .7 to 3. AE .5 cmH 2 O/L/s (P < 0.01), while X5 was significantly changed into less negative from -1.2 AE 0.9 to -0.9 AE 0.6 cm H 2 O/L/s (P < 0.01).
These results suggest that the weight loss therapy reduced BMI, FM and increased SM, VC, and ERV, which were accompanied by the change of R5 into decreased and X5 into less negative in the obese patients. Methods: A 24-year-old male presented with productive cough, dyspnea and puffiness of the face for 8 months. Work up revealed a mass noted on Chest X-ray. CT scan revealed, a 9.8 × 12.0 × 8.7 cm lobulated mass occupying the anterior and middle mediastinal mass, partially encasing the ascending aorta. CT-guided aspiration biopsy was done but results were non-diagnostic. Beta HCG and serum AFP were normal. He was lost to follow up for several months until he became more symptomatic. Repeat cxr revealed pleural effusion on the right. Chest CT scan revealed a large lobulated, mixed attenuation mediastinal mass. CT guided biopsy was done but was non-diagnostic, hence patient underwent anterior mediastinotomy.
Results: LDH was slightly elevated, beta HCG and AFP were both normal. Histopathology revealed round cell proliferation with considerations of lymphoma and seminoma. Immunohistochemistry panel was done, CD117 positive, EMA negative and S100 negative confirmed the diagnosis of seminoma.
Normal beta HCG and AFB and immunohistochemistry results confirmed the diagnosis of a primary mediastinal seminoma.
The patient underwent several sessions of radiotherapy, with noted resolution of the symptoms of SVC. He was referred to oncology service for the initiation of chemotherapy.
